Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Market Cap	347.84B
Revenue (ttm)	83.27B
Net Income (ttm)	-16.47B
Shares Out	49.55M
EPS (ttm)	-337.74
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	595,280
Average Volume	756,593
Open	7,900.00
Previous Close	7,870.00
Day's Range	7,820.00 - 8,160.00
52-Week Range	3,495.00 - 13,600.00
Beta	-0.74
RSI	43.09
Earnings Date	Nov 14, 2025

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED...

• Industry: Electronic Components, not elsewhere classified
• Founded: 2002
• Employees: 307
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082800

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.